GO:0048793 | pronephros development | 100.0% (2/2) | 10.8 | 0.0 | 2e-05 |
GO:0060212 | negative regulation of nuclear-transcribed mRNA poly(A) tail shortening | 100.0% (2/2) | 10.86 | 0.0 | 2.5e-05 |
GO:1900152 | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 100.0% (2/2) | 10.86 | 0.0 | 2.5e-05 |
GO:0010501 | RNA secondary structure unwinding | 100.0% (2/2) | 11.35 | 0.0 | 3.7e-05 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 100.0% (2/2) | 10.04 | 1e-06 | 4.7e-05 |
GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 100.0% (2/2) | 9.8 | 1e-06 | 4.7e-05 |
GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 100.0% (2/2) | 9.83 | 1e-06 | 5.3e-05 |
GO:0022008 | neurogenesis | 100.0% (2/2) | 9.21 | 3e-06 | 6.8e-05 |
GO:0048255 | mRNA stabilization | 100.0% (2/2) | 9.21 | 3e-06 | 6.8e-05 |
GO:0006406 | mRNA export from nucleus | 100.0% (2/2) | 8.97 | 4e-06 | 7.5e-05 |
GO:0050685 | positive regulation of mRNA processing | 100.0% (2/2) | 9.06 | 3e-06 | 7.7e-05 |
GO:1902373 | negative regulation of mRNA catabolic process | 100.0% (2/2) | 9.01 | 4e-06 | 7.7e-05 |
GO:0001822 | kidney development | 100.0% (2/2) | 8.85 | 5e-06 | 7.8e-05 |
GO:0033120 | positive regulation of RNA splicing | 100.0% (2/2) | 8.85 | 5e-06 | 7.8e-05 |
GO:0007369 | gastrulation | 100.0% (2/2) | 9.32 | 2e-06 | 8e-05 |
GO:0048026 | positive regulation of mRNA splicing, via spliceosome | 100.0% (2/2) | 9.23 | 3e-06 | 8.1e-05 |
GO:1902369 | negative regulation of RNA catabolic process | 100.0% (2/2) | 8.54 | 7e-06 | 8.7e-05 |
GO:1903312 | negative regulation of mRNA metabolic process | 100.0% (2/2) | 8.54 | 7e-06 | 8.7e-05 |
GO:0043489 | RNA stabilization | 100.0% (2/2) | 8.68 | 6e-06 | 9.2e-05 |
GO:0043022 | ribosome binding | 100.0% (2/2) | 8.55 | 7e-06 | 9.4e-05 |
GO:0006405 | RNA export from nucleus | 100.0% (2/2) | 8.63 | 6e-06 | 9.5e-05 |
GO:0032508 | DNA duplex unwinding | 100.0% (2/2) | 8.57 | 7e-06 | 9.7e-05 |
GO:0032392 | DNA geometric change | 100.0% (2/2) | 8.37 | 9e-06 | 0.000105 |
GO:0003730 | mRNA 3'-UTR binding | 100.0% (2/2) | 8.31 | 1e-05 | 0.00011 |
GO:0071103 | DNA conformation change | 100.0% (2/2) | 8.18 | 1.2e-05 | 0.000127 |
GO:0010043 | response to zinc ion | 100.0% (2/2) | 8.15 | 1.2e-05 | 0.000128 |
GO:0051028 | mRNA transport | 100.0% (2/2) | 8.04 | 1.4e-05 | 0.000138 |
GO:0051168 | nuclear export | 100.0% (2/2) | 8.04 | 1.4e-05 | 0.000138 |
GO:0016554 | cytidine to uridine editing | 100.0% (2/2) | 7.95 | 1.6e-05 | 0.00015 |
GO:0016553 | base conversion or substitution editing | 100.0% (2/2) | 7.87 | 1.8e-05 | 0.000162 |
GO:0051236 | establishment of RNA localization | 100.0% (2/2) | 7.7 | 2.3e-05 | 0.000181 |
GO:0050657 | nucleic acid transport | 100.0% (2/2) | 7.71 | 2.3e-05 | 0.000185 |
GO:0050658 | RNA transport | 100.0% (2/2) | 7.71 | 2.3e-05 | 0.000185 |
GO:0000398 | mRNA splicing, via spliceosome | 100.0% (2/2) | 7.66 | 2.4e-05 | 0.000186 |
GO:0048024 | regulation of mRNA splicing, via spliceosome | 100.0% (2/2) | 7.72 | 2.3e-05 | 0.000195 |
GO:0043488 | regulation of mRNA stability | 100.0% (2/2) | 7.58 | 2.7e-05 | 0.000202 |
GO:0080156 | mitochondrial mRNA modification | 100.0% (2/2) | 7.55 | 2.8e-05 | 0.000204 |
GO:0031330 | negative regulation of cellular catabolic process | 100.0% (2/2) | 7.31 | 3.9e-05 | 0.000207 |
GO:0043484 | regulation of RNA splicing | 100.0% (2/2) | 7.31 | 3.9e-05 | 0.000207 |
GO:0003697 | single-stranded DNA binding | 100.0% (2/2) | 7.49 | 3.1e-05 | 0.000211 |
GO:1903313 | positive regulation of mRNA metabolic process | 100.0% (2/2) | 7.51 | 3e-05 | 0.000212 |
GO:0050684 | regulation of mRNA processing | 100.0% (2/2) | 7.38 | 3.6e-05 | 0.000213 |
GO:0061013 | regulation of mRNA catabolic process | 100.0% (2/2) | 7.38 | 3.6e-05 | 0.000213 |
GO:0016477 | cell migration | 100.0% (2/2) | 7.47 | 3.2e-05 | 0.000213 |
GO:0000375 | RNA splicing, via transesterification reactions | 100.0% (2/2) | 7.32 | 3.9e-05 | 0.000214 |
GO:0045727 | positive regulation of translation | 100.0% (2/2) | 7.43 | 3.4e-05 | 0.000214 |
GO:0051169 | nuclear transport | 100.0% (2/2) | 7.33 | 3.8e-05 | 0.000215 |
GO:0006913 | nucleocytoplasmic transport | 100.0% (2/2) | 7.34 | 3.8e-05 | 0.000216 |
GO:0043021 | ribonucleoprotein complex binding | 100.0% (2/2) | 7.4 | 3.5e-05 | 0.000217 |
GO:0005507 | copper ion binding | 100.0% (2/2) | 7.27 | 4.2e-05 | 0.000217 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 100.0% (2/2) | 7.35 | 3.7e-05 | 0.000217 |
GO:0043487 | regulation of RNA stability | 100.0% (2/2) | 7.43 | 3.3e-05 | 0.000218 |
GO:0034250 | positive regulation of cellular amide metabolic process | 100.0% (2/2) | 7.24 | 4.3e-05 | 0.000219 |
GO:0048870 | cell motility | 100.0% (2/2) | 7.22 | 4.5e-05 | 0.000222 |
GO:0016556 | mRNA modification | 100.0% (2/2) | 7.13 | 5.1e-05 | 0.000247 |
GO:1900864 | mitochondrial RNA modification | 100.0% (2/2) | 7.1 | 5.3e-05 | 0.000252 |
GO:0010228 | vegetative to reproductive phase transition of meristem | 100.0% (2/2) | 7.0 | 6.1e-05 | 0.000287 |
GO:0005681 | spliceosomal complex | 100.0% (2/2) | 6.96 | 6.4e-05 | 0.000295 |
GO:0009792 | embryo development ending in birth or egg hatching | 100.0% (2/2) | 6.95 | 6.5e-05 | 0.000296 |
GO:0015931 | nucleobase-containing compound transport | 100.0% (2/2) | 6.93 | 6.7e-05 | 0.000298 |
GO:0009895 | negative regulation of catabolic process | 100.0% (2/2) | 6.9 | 7e-05 | 0.000307 |
GO:0048598 | embryonic morphogenesis | 100.0% (2/2) | 6.84 | 7.6e-05 | 0.000328 |
GO:0008380 | RNA splicing | 100.0% (2/2) | 6.73 | 8.8e-05 | 0.000374 |
GO:0000959 | mitochondrial RNA metabolic process | 100.0% (2/2) | 6.61 | 0.000104 | 0.000437 |
GO:1903311 | regulation of mRNA metabolic process | 100.0% (2/2) | 6.58 | 0.000109 | 0.00045 |
GO:0051276 | chromosome organization | 100.0% (2/2) | 6.28 | 0.000166 | 0.000674 |
GO:0006397 | mRNA processing | 100.0% (2/2) | 6.2 | 0.000185 | 0.00074 |
GO:0005777 | peroxisome | 100.0% (2/2) | 6.16 | 0.000195 | 0.00077 |
GO:0009451 | RNA modification | 100.0% (2/2) | 5.99 | 0.000248 | 0.000963 |
GO:0006417 | regulation of translation | 100.0% (2/2) | 5.96 | 0.000257 | 0.00097 |
GO:0007623 | circadian rhythm | 100.0% (2/2) | 5.97 | 0.000255 | 0.000977 |
GO:0042579 | microbody | 100.0% (2/2) | 5.9 | 0.000281 | 0.001047 |
GO:0010119 | regulation of stomatal movement | 100.0% (2/2) | 5.88 | 0.000288 | 0.001058 |
GO:0034248 | regulation of cellular amide metabolic process | 100.0% (2/2) | 5.87 | 0.000293 | 0.001062 |
GO:0048511 | rhythmic process | 100.0% (2/2) | 5.83 | 0.000308 | 0.001102 |
GO:0031329 | regulation of cellular catabolic process | 100.0% (2/2) | 5.62 | 0.000413 | 0.001457 |
GO:0010608 | post-transcriptional regulation of gene expression | 100.0% (2/2) | 5.56 | 0.000447 | 0.001556 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 100.0% (2/2) | 5.54 | 0.000459 | 0.001577 |
GO:0046686 | response to cadmium ion | 100.0% (2/2) | 5.43 | 0.000539 | 0.001829 |
GO:0010628 | positive regulation of gene expression | 100.0% (2/2) | 5.41 | 0.000553 | 0.001854 |
GO:0016071 | mRNA metabolic process | 100.0% (2/2) | 5.32 | 0.000627 | 0.002073 |
GO:0009894 | regulation of catabolic process | 100.0% (2/2) | 5.27 | 0.000675 | 0.002206 |
GO:0045087 | innate immune response | 100.0% (2/2) | 5.25 | 0.000687 | 0.002218 |
GO:0044877 | protein-containing complex binding | 100.0% (2/2) | 5.24 | 0.000703 | 0.002243 |
GO:0051247 | positive regulation of protein metabolic process | 100.0% (2/2) | 5.2 | 0.000735 | 0.002317 |
GO:1990904 | ribonucleoprotein complex | 100.0% (2/2) | 5.13 | 0.000814 | 0.00248 |
GO:0006955 | immune response | 100.0% (2/2) | 5.13 | 0.00081 | 0.002495 |
GO:0048513 | animal organ development | 100.0% (2/2) | 5.14 | 0.000801 | 0.002497 |
GO:0043023 | ribosomal large subunit binding | 50.0% (1/2) | 9.73 | 0.001177 | 0.003543 |
GO:0046907 | intracellular transport | 100.0% (2/2) | 4.85 | 0.001201 | 0.003576 |
GO:0051253 | negative regulation of RNA metabolic process | 100.0% (2/2) | 4.77 | 0.001341 | 0.00395 |
GO:0140513 | nuclear protein-containing complex | 100.0% (2/2) | 4.72 | 0.001446 | 0.004123 |
GO:0070181 | small ribosomal subunit rRNA binding | 50.0% (1/2) | 9.45 | 0.001432 | 0.004127 |
GO:0009790 | embryo development | 100.0% (2/2) | 4.73 | 0.001419 | 0.004134 |
GO:0046914 | transition metal ion binding | 100.0% (2/2) | 4.67 | 0.001549 | 0.00437 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 4.64 | 0.001614 | 0.004507 |
GO:0051649 | establishment of localization in cell | 100.0% (2/2) | 4.63 | 0.001641 | 0.004534 |
GO:0010038 | response to metal ion | 100.0% (2/2) | 4.57 | 0.001764 | 0.004823 |
GO:0009737 | response to abscisic acid | 100.0% (2/2) | 4.53 | 0.001879 | 0.004938 |
GO:0003729 | mRNA binding | 100.0% (2/2) | 4.55 | 0.001824 | 0.004939 |
GO:0006396 | RNA processing | 100.0% (2/2) | 4.53 | 0.001868 | 0.004957 |
GO:0009507 | chloroplast | 100.0% (2/2) | 4.53 | 0.001864 | 0.004995 |
GO:0009409 | response to cold | 100.0% (2/2) | 4.51 | 0.001928 | 0.005018 |
GO:0009414 | response to water deprivation | 100.0% (2/2) | 4.46 | 0.002077 | 0.005353 |
GO:0002376 | immune system process | 100.0% (2/2) | 4.43 | 0.002143 | 0.00547 |
GO:0009651 | response to salt stress | 100.0% (2/2) | 4.39 | 0.002261 | 0.00561 |
GO:0009415 | response to water | 100.0% (2/2) | 4.4 | 0.002253 | 0.005644 |
GO:0030154 | cell differentiation | 100.0% (2/2) | 4.4 | 0.002251 | 0.005691 |
GO:0097305 | response to alcohol | 100.0% (2/2) | 4.36 | 0.002382 | 0.005855 |
GO:0071705 | nitrogen compound transport | 100.0% (2/2) | 4.34 | 0.002452 | 0.005974 |
GO:0001101 | response to acid chemical | 100.0% (2/2) | 4.31 | 0.002531 | 0.006111 |
GO:0005739 | mitochondrion | 100.0% (2/2) | 4.28 | 0.002633 | 0.006243 |
GO:0005524 | ATP binding | 100.0% (2/2) | 4.29 | 0.002614 | 0.006255 |
GO:0051254 | positive regulation of RNA metabolic process | 100.0% (2/2) | 4.24 | 0.002784 | 0.006545 |
GO:0034063 | stress granule assembly | 50.0% (1/2) | 8.47 | 0.002812 | 0.006554 |
GO:0051246 | regulation of protein metabolic process | 100.0% (2/2) | 4.17 | 0.003072 | 0.006804 |
GO:0030554 | adenyl nucleotide binding | 100.0% (2/2) | 4.17 | 0.003069 | 0.006855 |
GO:0010557 | positive regulation of macromolecule biosynthetic process | 100.0% (2/2) | 4.18 | 0.003058 | 0.006887 |
GO:0032559 | adenyl ribonucleotide binding | 100.0% (2/2) | 4.18 | 0.003038 | 0.0069 |
GO:0003690 | double-stranded DNA binding | 100.0% (2/2) | 4.19 | 0.003018 | 0.006914 |
GO:0019899 | enzyme binding | 100.0% (2/2) | 4.19 | 0.003004 | 0.006941 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 4.13 | 0.003259 | 0.00716 |
GO:0006970 | response to osmotic stress | 100.0% (2/2) | 4.11 | 0.003333 | 0.007261 |
GO:0016070 | RNA metabolic process | 100.0% (2/2) | 4.07 | 0.003561 | 0.007398 |
GO:0071702 | organic substance transport | 100.0% (2/2) | 4.07 | 0.003561 | 0.007398 |
GO:0051641 | cellular localization | 100.0% (2/2) | 4.08 | 0.003488 | 0.007419 |
GO:0009536 | plastid | 100.0% (2/2) | 4.08 | 0.003482 | 0.007465 |
GO:0035639 | purine ribonucleoside triphosphate binding | 100.0% (2/2) | 4.09 | 0.003458 | 0.007474 |
GO:0030371 | translation repressor activity | 50.0% (1/2) | 8.1 | 0.00363 | 0.007483 |
GO:0031324 | negative regulation of cellular metabolic process | 100.0% (2/2) | 4.07 | 0.003549 | 0.007489 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 100.0% (2/2) | 4.05 | 0.003662 | 0.007493 |
GO:0031328 | positive regulation of cellular biosynthetic process | 100.0% (2/2) | 4.0 | 0.003911 | 0.007941 |
GO:0017076 | purine nucleotide binding | 100.0% (2/2) | 3.97 | 0.004076 | 0.008092 |
GO:0009891 | positive regulation of biosynthetic process | 100.0% (2/2) | 3.97 | 0.00405 | 0.0081 |
GO:0032555 | purine ribonucleotide binding | 100.0% (2/2) | 3.98 | 0.004024 | 0.008108 |
GO:0009266 | response to temperature stimulus | 100.0% (2/2) | 3.96 | 0.004145 | 0.008168 |
GO:0032553 | ribonucleotide binding | 100.0% (2/2) | 3.94 | 0.004251 | 0.008256 |
GO:0003723 | RNA binding | 100.0% (2/2) | 3.94 | 0.004221 | 0.008257 |
GO:0035196 | miRNA processing | 50.0% (1/2) | 7.81 | 0.004447 | 0.008573 |
GO:0007275 | multicellular organism development | 100.0% (2/2) | 3.89 | 0.004553 | 0.008716 |
GO:0097367 | carbohydrate derivative binding | 100.0% (2/2) | 3.86 | 0.004756 | 0.009039 |
GO:0010605 | negative regulation of macromolecule metabolic process | 100.0% (2/2) | 3.78 | 0.005292 | 0.009988 |
GO:0048869 | cellular developmental process | 100.0% (2/2) | 3.74 | 0.005575 | 0.010448 |
GO:0009506 | plasmodesma | 100.0% (2/2) | 3.68 | 0.006095 | 0.011187 |
GO:0006996 | organelle organization | 100.0% (2/2) | 3.68 | 0.006079 | 0.011235 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 100.0% (2/2) | 3.68 | 0.006051 | 0.011261 |
GO:0031490 | chromatin DNA binding | 50.0% (1/2) | 7.34 | 0.006182 | 0.01127 |
GO:0005911 | cell-cell junction | 100.0% (2/2) | 3.64 | 0.00641 | 0.011608 |
GO:0070161 | anchoring junction | 100.0% (2/2) | 3.63 | 0.006509 | 0.011629 |
GO:0009892 | negative regulation of metabolic process | 100.0% (2/2) | 3.63 | 0.006492 | 0.011678 |
GO:0090304 | nucleic acid metabolic process | 100.0% (2/2) | 3.6 | 0.006801 | 0.012071 |
GO:0031325 | positive regulation of cellular metabolic process | 100.0% (2/2) | 3.59 | 0.006856 | 0.012088 |
GO:0010604 | positive regulation of macromolecule metabolic process | 100.0% (2/2) | 3.58 | 0.007009 | 0.012278 |
GO:0043168 | anion binding | 100.0% (2/2) | 3.56 | 0.007152 | 0.012365 |
GO:0003677 | DNA binding | 100.0% (2/2) | 3.57 | 0.00713 | 0.012408 |
GO:0033993 | response to lipid | 100.0% (2/2) | 3.5 | 0.007806 | 0.013241 |
GO:0043228 | non-membrane-bounded organelle | 100.0% (2/2) | 3.5 | 0.007797 | 0.01331 |
GO:0043232 | intracellular non-membrane-bounded organelle | 100.0% (2/2) | 3.5 | 0.007797 | 0.01331 |
GO:0009653 | anatomical structure morphogenesis | 100.0% (2/2) | 3.49 | 0.00792 | 0.013349 |
GO:0070918 | small regulatory ncRNA processing | 50.0% (1/2) | 6.93 | 0.00817 | 0.013685 |
GO:0010494 | cytoplasmic stress granule | 50.0% (1/2) | 6.91 | 0.008323 | 0.013854 |
GO:0030054 | cell junction | 100.0% (2/2) | 3.43 | 0.008594 | 0.014217 |
GO:0009893 | positive regulation of metabolic process | 100.0% (2/2) | 3.37 | 0.00929 | 0.015275 |
GO:0010035 | response to inorganic substance | 100.0% (2/2) | 3.35 | 0.009659 | 0.015784 |
GO:0051252 | regulation of RNA metabolic process | 100.0% (2/2) | 3.34 | 0.009805 | 0.015926 |
GO:0000166 | nucleotide binding | 100.0% (2/2) | 3.3 | 0.010308 | 0.016444 |
GO:1901265 | nucleoside phosphate binding | 100.0% (2/2) | 3.3 | 0.010308 | 0.016444 |
GO:0006139 | nucleobase-containing compound metabolic process | 100.0% (2/2) | 3.31 | 0.010194 | 0.016458 |
GO:0010556 | regulation of macromolecule biosynthetic process | 100.0% (2/2) | 3.23 | 0.011368 | 0.018027 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 100.0% (2/2) | 3.22 | 0.011593 | 0.018275 |
GO:0046872 | metal ion binding | 100.0% (2/2) | 3.21 | 0.011675 | 0.018298 |
GO:0009725 | response to hormone | 100.0% (2/2) | 3.16 | 0.0126 | 0.01897 |
GO:0036094 | small molecule binding | 100.0% (2/2) | 3.16 | 0.012571 | 0.019034 |
GO:0043169 | cation binding | 100.0% (2/2) | 3.18 | 0.012223 | 0.019046 |
GO:0019843 | rRNA binding | 50.0% (1/2) | 6.32 | 0.012446 | 0.01906 |
GO:0006810 | transport | 100.0% (2/2) | 3.17 | 0.012308 | 0.019067 |
GO:0098542 | defense response to other organism | 100.0% (2/2) | 3.17 | 0.012399 | 0.019098 |
GO:0048523 | negative regulation of cellular process | 100.0% (2/2) | 3.16 | 0.012542 | 0.019098 |
GO:0065008 | regulation of biological quality | 100.0% (2/2) | 3.11 | 0.013322 | 0.019946 |
GO:0051234 | establishment of localization | 100.0% (2/2) | 3.11 | 0.013446 | 0.02002 |
GO:0009719 | response to endogenous stimulus | 100.0% (2/2) | 3.06 | 0.014412 | 0.021107 |
GO:0043412 | macromolecule modification | 100.0% (2/2) | 3.06 | 0.014339 | 0.021114 |
GO:0045182 | translation regulator activity | 50.0% (1/2) | 6.12 | 0.014326 | 0.021212 |
GO:0031326 | regulation of cellular biosynthetic process | 100.0% (2/2) | 3.01 | 0.015348 | 0.022234 |
GO:0032991 | protein-containing complex | 100.0% (2/2) | 3.02 | 0.015279 | 0.022254 |
GO:0010468 | regulation of gene expression | 100.0% (2/2) | 2.96 | 0.016399 | 0.023502 |
GO:0009889 | regulation of biosynthetic process | 100.0% (2/2) | 2.97 | 0.016366 | 0.023582 |
GO:0046483 | heterocycle metabolic process | 100.0% (2/2) | 2.92 | 0.017336 | 0.024713 |
GO:0140694 | non-membrane-bounded organelle assembly | 50.0% (1/2) | 5.82 | 0.017676 | 0.025065 |
GO:0051179 | localization | 100.0% (2/2) | 2.9 | 0.017845 | 0.025171 |
GO:0006952 | defense response | 100.0% (2/2) | 2.89 | 0.018237 | 0.025589 |
GO:0034641 | cellular nitrogen compound metabolic process | 100.0% (2/2) | 2.87 | 0.018591 | 0.02595 |
GO:0048522 | positive regulation of cellular process | 100.0% (2/2) | 2.85 | 0.019139 | 0.026576 |
GO:0005829 | cytosol | 100.0% (2/2) | 2.81 | 0.020325 | 0.027791 |
GO:0003006 | developmental process involved in reproduction | 100.0% (2/2) | 2.81 | 0.020201 | 0.027906 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 50.0% (1/2) | 5.61 | 0.020312 | 0.027915 |
GO:0035770 | ribonucleoprotein granule | 50.0% (1/2) | 5.59 | 0.020615 | 0.028045 |
GO:0051171 | regulation of nitrogen compound metabolic process | 100.0% (2/2) | 2.78 | 0.02118 | 0.028523 |
GO:0003676 | nucleic acid binding | 100.0% (2/2) | 2.78 | 0.021157 | 0.028637 |
GO:0051707 | response to other organism | 100.0% (2/2) | 2.74 | 0.02238 | 0.02999 |
GO:0006725 | cellular aromatic compound metabolic process | 100.0% (2/2) | 2.73 | 0.022757 | 0.030343 |
GO:0048519 | negative regulation of biological process | 100.0% (2/2) | 2.7 | 0.023543 | 0.031235 |
GO:0044419 | biological process involved in interspecies interaction between organisms | 100.0% (2/2) | 2.7 | 0.023693 | 0.031279 |
GO:0080090 | regulation of primary metabolic process | 100.0% (2/2) | 2.69 | 0.024112 | 0.031676 |
GO:0060255 | regulation of macromolecule metabolic process | 100.0% (2/2) | 2.66 | 0.024978 | 0.032654 |
GO:0043207 | response to external biotic stimulus | 100.0% (2/2) | 2.64 | 0.025686 | 0.033417 |
GO:0016043 | cellular component organization | 100.0% (2/2) | 2.61 | 0.026671 | 0.034037 |
GO:1901700 | response to oxygen-containing compound | 100.0% (2/2) | 2.61 | 0.026671 | 0.034037 |
GO:0031323 | regulation of cellular metabolic process | 100.0% (2/2) | 2.62 | 0.026604 | 0.034279 |
GO:0009607 | response to biotic stimulus | 100.0% (2/2) | 2.62 | 0.026563 | 0.03439 |
GO:1901360 | organic cyclic compound metabolic process | 100.0% (2/2) | 2.6 | 0.027268 | 0.034471 |
GO:0070925 | organelle assembly | 50.0% (1/2) | 5.19 | 0.027187 | 0.034532 |
GO:0048518 | positive regulation of biological process | 100.0% (2/2) | 2.53 | 0.029835 | 0.037539 |
GO:0071840 | cellular component organization or biogenesis | 100.0% (2/2) | 2.52 | 0.030234 | 0.037863 |
GO:0022414 | reproductive process | 100.0% (2/2) | 2.51 | 0.030977 | 0.038613 |
GO:0032501 | multicellular organismal process | 100.0% (2/2) | 2.47 | 0.032398 | 0.040197 |
GO:0010033 | response to organic substance | 100.0% (2/2) | 2.46 | 0.033055 | 0.040636 |
GO:0003682 | chromatin binding | 50.0% (1/2) | 4.9 | 0.033234 | 0.04067 |
GO:0043167 | ion binding | 100.0% (2/2) | 2.46 | 0.032934 | 0.040674 |
GO:0009411 | response to UV | 50.0% (1/2) | 4.83 | 0.034944 | 0.042568 |
GO:0009628 | response to abiotic stimulus | 100.0% (2/2) | 2.38 | 0.036714 | 0.044522 |
GO:0019222 | regulation of metabolic process | 100.0% (2/2) | 2.38 | 0.036999 | 0.044665 |
GO:0048856 | anatomical structure development | 100.0% (2/2) | 2.33 | 0.039796 | 0.047613 |
GO:0009605 | response to external stimulus | 100.0% (2/2) | 2.33 | 0.039704 | 0.047716 |